News & Updates
Filter by Specialty:
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
Receipt of a booster dose of the COVID-19 vaccine reduces the risk of breakthrough COVID-19 infections* compared to full vaccination only, particularly among individuals without immunosuppressed/compromised conditions (ISC), according to a US study presented at CROI 2022.
Booster COVID-19 vacc cuts breakthrough infection risk, particularly in individuals with no immune dysfunction
17 Mar 2022
Investigational DP2 antagonist strikes out in eosinophilic asthma
The prostaglandin D2 receptor 2 (DP2) antagonist GB001 does not appear to significantly lower the risk of disease worsening in patients with moderate-to-severe eosinophilic asthma, according to data from a phase IIb trial.
Investigational DP2 antagonist strikes out in eosinophilic asthma
13 Mar 2022
Vitamin D deficiency tied to severe COVID-19
A systematic review and meta-analysis of >8,000 adult and elderly patients with COVID-19 showed a positive association between vitamin D deficiency (ie, 25(OH)D <50 nmol/L) and severe COVID-19.
Vitamin D deficiency tied to severe COVID-19
13 Mar 2022
Shorter antibiotic regimen enough in kids with pneumonia?
Children with non-severe community-acquired pneumonia (CAP) may benefit from a 5-day antibiotic regimen compared with the current standard regimen of 10 days, according to results of the US-based SCOUT-CAP trial.
Shorter antibiotic regimen enough in kids with pneumonia?
10 Mar 2022
Delamanid-based regimens work against multidrug-resistant tuberculosis
The use of delamanid-containing regimens is safe and effective in the management of multidrug-resistant tuberculosis (MDR-TB), with high culture conversion and treatment success rates despite extensive resistance patterns, according to the results of a meta-analysis.
